Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of T-1220 (piperacillin sodium) in patients with bacterial infectious disease
jRCT2080221672Phase 3
- Sponsor
- Fujifilm
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of piperacillin in bacterial disease, sponsored by Fujifilm.
02
Drugs
03
Conditions
bacterial disease
Beyond the preview
Go deeper on jRCT2080221672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221672.